Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI CHIMIE Gentilly FR
02 1CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai IN
03 1CENTIPHARM Grasse FR
04 2F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore IT
01 4Tetrazepam
02 1Tetrazepam, Process 2
01 2France
02 1India
03 2Italy
01 1Valid
02 4Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2008-288 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2010-07-27
Type : Chemical
Substance Number : 1738
Certificate Number : R0-CEP 2011-186 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2017-06-08
Type : Chemical
Substance Number : 1738
Certificate Number : R1-CEP 2007-003 - Rev 00
Status : Valid
Issue Date : 2013-01-29
Type : Chemical
Substance Number : 1738
Certificate Number : R1-CEP 2012-097 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2017-10-05
Type : Chemical
Substance Number : 1738
Certificate Number : R1-CEP 2008-152 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2015-02-13
Type : Chemical
Substance Number : 1738
A Tetrazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrazepam, including repackagers and relabelers. The FDA regulates Tetrazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetrazepam supplier is an individual or a company that provides Tetrazepam active pharmaceutical ingredient (API) or Tetrazepam finished formulations upon request. The Tetrazepam suppliers may include Tetrazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tetrazepam CEP of the European Pharmacopoeia monograph is often referred to as a Tetrazepam Certificate of Suitability (COS). The purpose of a Tetrazepam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tetrazepam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tetrazepam to their clients by showing that a Tetrazepam CEP has been issued for it. The manufacturer submits a Tetrazepam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tetrazepam CEP holder for the record. Additionally, the data presented in the Tetrazepam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tetrazepam DMF.
A Tetrazepam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tetrazepam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tetrazepam suppliers with CEP (COS) on PharmaCompass.
We have 4 companies offering Tetrazepam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
